Health-tech startup Tempus AI has filed for a $100 million initial public offering (IPO). The Chicago-based company uses artificial intelligence to process medical data and aims to unlock the power of precision medicine through Intelligent Diagnostics. According to its SEC filing, Tempus AI reported a net loss of $266 million on $532 million in revenue for 2023. The company employs 2,300 staff and has a revenue run rate of approximately $580 million. The IPO filing is under the ticker $TEM and includes an S-1 registration.